Intracranial thrombectomy using the Solitaire stent: a historical vignette
- 1Klinik für Neuroradiologie, Katharinenhospital, Klinikum Stuttgart, Germany
- 2Klinik für Neurologie, Bürgerhospital, Klinikum Stuttgart, Germany
- 3Medizinische Fakultät der Universität Duisburg-Essen, Germany
- Correspondence to Professor H Henkes, Klinik für Neuroradiologie, Katharinenhospital, Neurozentrum, Klinikum Stuttgart, Kriegsbergstrasse 60, D-70174 Stuttgart, Germany; hhhenkes{at}aol.com
-
Contributors MAP, EM and SF wrote the first draft of the manuscript, which was revised by HB and HH. HH performed the endovascular treatment. HB reviewed the neurological aspects.
- Received 25 September 2011
- Revised 2 November 2011
- Accepted 13 November 2011
- Published Online First 14 December 2011
Abstract
Introduction The endovascular treatment of acute ischemic stroke has been revolutionized in the past years by the introduction of new devices for mechanical thrombectomy. Several tools were already available in 2008. The majority allowed the recanalization of acutely occluded intracranial arteries with acceptable levels of safety and efficacy, and with occasional failures.
Case presentation On 3 March 2008, a 67-year-old woman was treated 3.5 h after the clinical onset of a right hemispheric stroke due to an embolic middle cerebral artery (MCA) M1 occlusion. The National Institutes of Health Stroke Scale (NIHSS) score prior to treatment was 10. Mechanical thrombectomy with a microbrush yielded a significant amount of thrombotic material without recanalization. Given the urgency of the situation, the uncertain outcome in the case of a persistent occlusion of the right M1 segment and the fact that no other device was available, a Solitaire stent was deployed within the occluded right M1 segment. After several minutes of incubation, the expanded stent was slowly withdrawn under continuous aspiration with instantaneous removal of the entire thrombus and complete recanalization of the right MCA with reperfusion of the whole MCA supply territory. Digital subtraction angiography showed neither peripheral emboli nor vasospasm. The patient made a complete clinical recovery with an NIHSS score of 0 at the 30 day follow-up.
Conclusion The Solitaire stent was initially developed for the endovascular treatment of wide necked intracranial aneurysms but has been demonstrated to be safe and efficacious for intracranial thrombectomy. This was the first successful human clinical use of a Solitaire stent for this purpose and the ignition spark for the development of a whole generation of new devices, now called stent retrievers.
Footnotes
-
Competing interests The senior author is the co-inventor of the Solitaire stent but has no further interest in this product. ev3 has paid the open access charges for this article.
-
Patient consent Obtained.
-
Provenance and peer review Not commissioned; externally peer reviewed.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
